Halliday Mark, Radford Helois, Mallucci Giovanna R
From the Medical Research Council (MRC) Toxicology Unit, Hodgkin Building, University of Leicester, Lancaster Road, Leicester LE1 9HN, United Kingdom.
From the Medical Research Council (MRC) Toxicology Unit, Hodgkin Building, University of Leicester, Lancaster Road, Leicester LE1 9HN, United Kingdom
J Biol Chem. 2014 Jul 18;289(29):19862-8. doi: 10.1074/jbc.R114.568477. Epub 2014 May 23.
Neurodegenerative diseases are characterized by the aggregation of misfolded proteins in the brain. Among these disorders are the prion diseases, which are transmissible, and in which the misfolded proteins ("prions") are also the infectious agent. Increasingly, it appears that misfolded proteins in Alzheimer and Parkinson diseases and the tauopathies also propagate in a "prion-like" manner. However, the association between prion formation, spread, and neurotoxicity is not clear. Recently, we showed that in prion disease, protein misfolding leads to neurodegeneration through dysregulation of generic proteostatic mechanisms, specifically, the unfolded protein response. Genetic and pharmacological manipulation of the unfolded protein response was neuroprotective despite continuing prion replication, hence dissociating this from neurotoxicity. The data have clear implications for treatment across the spectrum of these disorders, targeting pathogenic processes downstream of protein misfolding.
神经退行性疾病的特征是大脑中错误折叠的蛋白质聚集。这些疾病包括可传播的朊病毒疾病,其中错误折叠的蛋白质(“朊病毒”)也是传染因子。越来越多的证据表明,阿尔茨海默病、帕金森病和tau蛋白病中的错误折叠蛋白也以“朊病毒样”方式传播。然而,朊病毒形成、传播与神经毒性之间的关联尚不清楚。最近,我们发现,在朊病毒疾病中,蛋白质错误折叠通过通用蛋白质稳态机制的失调,特别是未折叠蛋白反应,导致神经退行性变。尽管朊病毒持续复制,但对未折叠蛋白反应进行基因和药理学操作具有神经保护作用,因此将其与神经毒性区分开来。这些数据对于针对这些疾病谱系进行治疗具有明确的意义,即针对蛋白质错误折叠下游的致病过程。